Golden Triangle Ventures Enters New Era with Strategic Restructuring and Market Expansion

(PinkSheets:GTVH),(Pinksheets:GTVH), LAS VEGAS, Aug. 07, 2025 (GLOBE NEWSWIRE) — via IBN — Golden Triangle Ventures, Inc. (OTC PINK: GTVH) (“GTVH” or the “Company”) is proud to announce a defining moment in its evolution — the execution of a binding Memorandum of Understanding (MOU) that brings the Company a new wave of leadership, high-growth assets, and […]

Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies

(NASDAQ:PCSA), VERO BEACH, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies for cancer patients, today announced that it has secured a strategic investment and that it is evaluating corporate cryptocurrency treasury strategies as part of its broader financial and growth objectives.

Alarum to Participate at the Canaccord Genuity 45th Annual Growth Conference on August 13, 2025

(NASDAQ:ALAR),(TASE:ALAR.TA), Presentation scheduled for Wednesday, August 13, 2025, at 8:30 a.m. ET Tel Aviv, Israel, Aug. 07, 2025 (GLOBE NEWSWIRE) — Alarum Technologies Ltd. (Nasdaq: ALAR, TASE: ALAR), a global provider of web data collection solutions, announced that its Chief Executive Officer, Mr. Shachar Daniel, will be attending the Canaccord Genuity Growth Conference on August

ZenaTech Acquires Cardinal Civil Resources, a Virginia-Based Land Surveying and Engineering Firm Serving Three States and Large Customers Including US Department of Transportation

(NASDAQ:ZENA),(Boerse Frankfurt – Freiverkehr:49Q),(BMV:ZENA), VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a business technology solution provider specializing in AI-powered drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, today announces the closing of its eighth and largest Drone as a Service

Trump Media Launches Great American Media Video Catalogue

(NasdaqGM:DJT), SARASOTA, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) — Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: DJT) (“Trump Media” or the “Company”), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand Truth.Fi, announced today that Truth+ has launched a slate of on-demand content from the Great

Aureus Greenway Holdings , Inc. Regains Compliance with Nasdaq Minimum Bid Price Rule

(NASDAQ:AGH), Kissimmee, FL, Aug. 07, 2025 (GLOBE NEWSWIRE) — Aureus Greenway Holdings Inc. (the “Company”, “Aureus Greenway”, “we”, “us”, “our”) (Nasdaq: AGH), an owner and operator of daily fee golf country clubs in the state of Florida, announced today that on August 6, 2025, the Company received written notice from The Nasdaq Stock Market LLC

Enact Receives Ratings Upgrade from Moody’s

(NASDAQ:ACT), RALEIGH, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) — Enact Holdings, Inc. (Nasdaq: ACT) (Enact) a leading provider of private mortgage insurance through its insurance subsidiaries, today announced that Moody's Investor Service (“Moody's”) upgraded the insurance financial strength rating for our flagship insurance subsidiary, Enact Mortgage Insurance Corporation, to A2 from A3. Moody's also announced

NetworkNewsAudio Announces Audio Press Release (APR) on Expanding Neural Tech Leadership in Booming AI Wearables Market

(NASDAQ:WLDS),(NASDAQ:WLDSW), AUSTIN, Texas, Aug. 07, 2025 (GLOBE NEWSWIRE) — via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “Neural Tech Drives the Growth of the AI Wearables Market,” featuring Wearable Devices Ltd. (NASDAQ: WLDS). To hear the NetworkNewsAudio version, visit https://nnw.fm/Cr4Sz To read the original editorial, visit https://nnw.fm/OZmoJ Wearable Devices Ltd. is emerging

Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11

(NASDAQ:DERM),(NASDAQ:FBIO), SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) — Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”, “we”, or “our”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that the management team of

Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum

(NASDAQ:INBS), Company anticipates fiscal fourth quarter sequential and year-on-year revenue growth of approximately 16% Company advanced efforts to secure U.S. FDA 510(k) clearance for planned U.S. market entry and strengthened global readiness through system upgrades and localization NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”),

Scroll to Top